27 Pharma Startups in France to Watch (and Work for) in 2023
Pharma is rapidly transforming the way we think about and interact with the world around us. Across Europe, but particulartly in France, Pharma startups are pushing boundaries, fixing problems worth solving, and reshaping the contours of their industry.
As we get into the end of 2023, we've curated a list of the top Pharma startups in France that are making waves. We update this list monthly by tracking activity in our database of 17,000 technology companies in Europe and sort them dynamically using our Seedtable score, ensuring objectivity.
Changelog
Last update: November 2, 2023. Updated the Investor Score. See changelog .
Rankings are calculated using our Seedtable score – a 1 to 100 score that uses quantitative and qualitative data points (examples are money raised or employees over time) to signal the momentum behind a company. A score closer to 100 indicates a company worth watching closely.
Featured companies in Company
Featured
SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic compli...
-
Latest Funding
$48 Million
-
Employees
1 to 10
-
Investors
Sofinnova Partners
-
Business Model
B2B
-
Industries
Health Tech, Hardware, Pharma, Manufacturing
-
Locations
Paris
-
Contact
•••••@safeheal.com
Unlock contact info
Featured
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
-
Latest Funding
$41 Million · Series B
-
Employees
1 to 10
-
Investors
Bpifrance, Idinvest Partners, Idinvest Partners, AGORANOV, Hadean Ventures
-
Business Model
B2B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Contact
•••••@step-ph.com
Unlock contact info
Featured
AI drug discovery platform.
-
Latest Funding
$16 Million · Series A
-
Employees
11 to 50
-
Investors
M Ventures
-
Industries
Pharma
-
Locations
Paris
-
Contact
•••••@iktos.ai
Unlock contact info
Full list of Pharma startups in France
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
-
Latest Funding
$29 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Nantes
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Sound Bioventures, Caixa Capital Risc
-
Contact
•••••@aboleris-pharma.com
Unlock contact info
Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.
-
Latest Funding
$43 Million · Series F
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Paris
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Omnes Capital, Nestlé Health Science, Seventure Partners
-
Contact
•••••@enterome.com
Unlock contact info
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.
-
Latest Funding
$6 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Fountain Healthcare Partners
-
Contact
•••••@ermium.com
Unlock contact info
Data capture for clinical trials.
-
Latest Funding
$2.4 Million · Seed
-
Industries
Health Tech, Pharma, Data and Analytics
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Bpifrance
-
Contact
•••••@kayentis.com
Unlock contact info
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
-
Latest Funding
$17 Million · Seed
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
XAnge, Quantonation
-
Contact
•••••@qubit-pharmaceuticals.com
Unlock contact info
ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.
-
Latest Funding
$100 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Marseille
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Eurazeo, Earlybird Venture Capital, Gimv, Andera Partners
-
Contact
•••••@imchecktherapeutics.com
Unlock contact info
Drug discovery - Pharma 3.0
-
Latest Funding
$29 Million · Series A
-
Industries
Health Tech, AI, Biotech, Machine Learning, Pharma, Quantum Computing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Elaia, Eurazeo
-
Contact
•••••@aqemia.com
Unlock contact info
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
-
Latest Funding
$11 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Entrepreneur First, Thia Ventures, XAnge, Plug and Play Spain
-
Contact
•••••@corebiogenesis.com
Unlock contact info
AI-powered data collecting tool for clinical trials.
-
Latest Funding
$20 Million · Series A
-
Industries
Health Tech, AI, Biotech, Machine Learning, Pharma
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Kima Ventures, Cathay Innovation, Serena, Fly Ventures
-
Contact
•••••@inato.com
Unlock contact info
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
-
Latest Funding
$75 Million
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Bordeaux
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
XAnge
-
Contact
•••••@treefrog.fr
Unlock contact info
Inventory management platform for pharmacists.
-
Latest Funding
$3.7 Million · Seed
-
Industries
Pharma
-
Locations
Toulouse
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
SideAngels
-
Contact
•••••@lecomptoirdespharmacies.fr
Unlock contact info
Livmed's is a software platform that provides home medicine delivery services for fellow citizens and healthcare players.
-
Latest Funding
$2.3 Million
-
Industries
Health Tech, Pharma
-
Locations
Nice
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Bpifrance
-
Contact
•••••@livmeds.com
Unlock contact info
Mablink Bioscience is a biotechnology company.
-
Latest Funding
$30 Million · Series A
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Lyon
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Sofinnova Partners, Elaia
-
Contact
•••••@mablink.com
Unlock contact info
Real-time drug data intelligence platform for healthcare professionals.
-
Latest Funding
$28 Million · Series B
-
Industries
Health Tech, Pharma, Business Intelligence
-
Locations
Bordeaux
-
Employees
51 to 100
-
Business Model
B2B, SAAS
-
Investors
XAnge
-
Contact
•••••@synapse-medicine.com
Unlock contact info
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.
-
Latest Funding
$1.4 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@everzom.com
Unlock contact info
Keenturtle is a medtech that provides e-health solutions to enhance medical & economic field such as provision of health data.
-
Latest Funding
$1.8 Million
-
Industries
Health Tech, Hardware, Pharma, Business Intelligence, Developer Tools
-
Locations
Paris
- Employees
-
Business Model
B2B, SAAS
-
Contact
•••••@keenturtle.com
Unlock contact info
Qairn is an IT company that offers a SaaS platform, risk management, and software development solutions.
-
Latest Funding
$1 Million
-
Industries
Health Tech, Fintech, Pharma, Legal Tech, Business Intelligence
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Contact
•••••@qairn.io
Unlock contact info
Lucine has the ambition to transform and improve patient’s health.
-
Latest Funding
$6.5 Million · Seed
-
Industries
Health Tech, Hardware, Biotech, Pharma, Data and Analytics, Manufacturing
-
Locations
Bordeaux
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@lucine.fr
Unlock contact info
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain.
-
Latest Funding
$7.9 Million · Series D
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Marseille
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@vect-horus.com
Unlock contact info
ABC Transfer is a biopharmaceutical company that develops Rapid Transfer Systems (RTS) solutions.
-
Latest Funding
$1 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Tours
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@abctransfer.fr
Unlock contact info
Meccellis Biotech is a manufacturer of tissue and cell and biomaterials.
-
Latest Funding
$5 Million
-
Industries
Health Tech, Hardware, Biotech, Deep Tech, Pharma
-
Locations
La Rochelle
-
Employees
11 to 50
-
Contact
•••••@meccellis.com
Unlock contact info
Emulseo develops and produces formulations for droplet-based microfluidic applications.
-
Latest Funding
$1.6 Million
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Bordeaux
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@emulseo.com
Unlock contact info
Signia Therapeutics is an innovative French start-up company.
-
Latest Funding
$1.5 Million · Series A
-
Industries
Health Tech, Pharma
-
Locations
Lyon
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@signiatherapeutics.com
Unlock contact info
Vaxxel is an Innovative viral live-attenuated platform for intranasal vaccine candidates preventing against pneumovirus infections
-
Latest Funding
$1.3 Million · Seed
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Lyon
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@vaxxel.fr
Unlock contact info